Dashboard
Manage Tickers

RDHLRedHill Biopharma Ltd.

Nasdaq redhillbio.com


$ 9.95 $ -0.39 (-3.77 %)    

Wednesday, 18-Sep-2024 13:08:12 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.99 $ -1.57 (-0.33 %)
DIA $ 416.26 $ -0.64 (-0.15 %)
SPY $ 562.20 $ -1.66 (-0.29 %)
TLT $ 99.62 $ -0.70 (-0.7 %)
GLD $ 235.53 $ -2.66 (-1.12 %)
$ 10.34
$ 9.95
-- x --
-- x --
$ 9.95 - $ 9.95
$ 6.43 - $ 82.00
17,150
na
527.21M
$ 1.38
$ 22.04
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

redhill-biopharma-announced-the-placement-of-low-dose-rifabutin-triple-therapy-talicia-as-an-empirically-prescribed-first-line-option-for-helicobacter-pylori-infection-in-the-newly-published-american-college-of-gastroenterology-clinical-guideline
RedHill Biopharma Announced The Placement ...
09/09/2024 11:14:47

redhill-biopharma-announced-the-publication-of-data-in-journal-microorganisms-from-the-phase-23-study-of-opaganib-in-covid-19-pneumonia-that-showed-62-reduction-in-covid-19-mortality
Redhill Biopharma Announced The Publicatio...
09/03/2024 11:14:12

Data, from a post hoc analysis of the randomized, placebo-controlled, double-blind phase 2/3 study of oral opaganib in COVID-19...

redhill-biopharma-h1-eps-000-down-from-004-yoy-sales-257m-down-from-539m-yoy
Redhill Biopharma H1 EPS $(0.00) Down From...
08/29/2024 11:07:46

redhill-biopharma-says-fda-granted-orphan-drug-designation-to-opaganib-for-treatment-of-neuroblastoma-a-type-of-childhood-cancer
RedHill Biopharma Says FDA Granted Orphan-...
08/26/2024 11:11:29

Orphan Drug designation provides for a seven-year marketing exclusivity period should opaganib be approved in neuroblastoma and...

redhill-biopharma-launched-talicia-omeprazole-magnesium-amoxicillin-and-rifabutin-in-the-united-arab-emirates-making-it-available-by-prescription-to-treat-adults-with-helicobacter-pylori-infection
Redhill Biopharma Launched Talicia (Omepra...
08/21/2024 11:25:54

The commercial launch of Talicia in the UAE triggers RedHill's eligibility for additional potential milestone payments, min...

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
08/20/2024 12:55:07

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
08/19/2024 23:50:04

israel-based-redhills-investigational-covid-19-treatment-shows-encouraging-action-in-obesity-and-diabetes
Israel-Based RedHill's Investigational COV...
08/19/2024 12:56:58

RedHill Biopharma released study results showing opaganib's potential in treating Type 2 diabetes and obesity. The drug'...

redhill-biopharmas-opaganib-demonstrates-impact-on-weight-and-glucose-in-preclinical-studies
RedHill Biopharma's Opaganib Demonstrates ...
08/19/2024 11:05:03

RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today...

redhill-biopharma-announces-plan-to-implement-ads-ratio-change-for-the-exchange-of-every-twenty-five-existing-ads-held-for-one-new-ads
Redhill Biopharma Announces Plan To Implem...
08/16/2024 11:07:29

crude-oil-moves-lower-moderna-shares-plunge
Crude Oil Moves Lower; Moderna Shares Plunge
08/01/2024 18:34:37

dow-dips-over-500-points-ism-manufacturing-pmi-falls-in-july
Dow Dips Over 500 Points; ISM Manufacturin...
08/01/2024 16:06:46

nasdaq-surges-1-meta-posts-upbeat-earnings
Nasdaq Surges 1%; Meta Posts Upbeat Earnings
08/01/2024 14:15:23

redhill-biopharma-announced-new-publication-of-data-showing-that-triple-antimicrobial-therapy-with-rhb-104-plus-standard-of-care-targeting-mycobacterium-avium-subspecies-paratuberculosis-is-64-more-effective-than-soc-alone-in-crohns-disease
RedHill Biopharma Announced New Publicatio...
08/01/2024 11:43:38

redhill-biopharma-terminates-agreement-with-movantik-acquisition-valinor-pharma-and-hcr-redhill-and-received-99m-in-cash-and-gained-full-control-over-an-additional-074m-currently-held-in-restricted-account
Redhill Biopharma Terminates Agreement Wit...
07/22/2024 11:14:53

In addition, the Agreement ends all existing credit ties with the Agreement parties, removes the existing lien against Talicia®...

redhill-biopharma-terminates-license-agreement-for-aemcolo-a-treatment-for-travelers-diarrhea-will-be-officially-terminated-on-october-8-2024
RedHill Biopharma Terminates License Agree...
07/09/2024 12:12:32

RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
06/18/2024 20:31:14

redhill-biopharma-has-received-a-notice-of-allowance-for-its-us-patent-application-17900235-titled-biomarkers-of-coronavirus-pneumonia-for-treating-coronavirus-infection-or-preventing-diseases-caused-by-coronavirus-infection
RedHill Biopharma Has Received A Notice Of...
06/18/2024 19:58:44

https://patentcenter.uspto.gov/applications/17900235/ifw/docs

redhill-biopharma-announced-new-chinese-patent-notice-of-allowance-for-opaganib-in-combination-with-immune-checkpoint-inhibitors-as-a-method-of-inducing-an-anti-cancer-immune-response-protecting-opaganibs-potential-use-through-2040
RedHill Biopharma Announced New Chinese Pa...
06/03/2024 11:05:33

redhill-announces-new-opaganib-chinese-patent-against-ebola-virus-valid-through-2035
RedHill Announces New Opaganib Chinese Pat...
05/06/2024 11:01:59

RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION